[Federal Register Volume 77, Number 247 (Wednesday, December 26, 2012)]
[Notices]
[Pages 76042-76043]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-31037]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Department of Health and Human Services, Office of the 
Assistant Secretary for Health, Presidential Commission for the Study 
of Bioethical Issues.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
(the Commission) will conduct its twelfth meeting in January. At this 
meeting, the Commission will continue discussing topics related to the 
ethical issues associated with the development of medical 
countermeasures for children.

DATES: The meeting will take place Monday and Tuesday, January 14-15, 
2013.

ADDRESSES: University of Miami Hospital Seminar Center, 1400 NW. 12th 
Avenue, First Floor, Miami, Florida 33136. Telephone (305) 689-5511.

FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications 
Director, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 
202-233-3960. Email: [email protected]. Additional 
information may be obtained at www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the twelfth meeting of the Commission. The meeting will be held from 
9 a.m. to approximately 5 p.m. on Monday, January 14, 2013, and from 9 
a.m. to approximately 11:45 a.m. on Tuesday, January 15, 2013, in 
Miami, Fla. The meeting will be open to the public with attendance 
limited to space available. The meeting will also be webcast at 
www.bioethics.gov.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established the Commission. The Commission is an advisory 
panel of the nation's leaders in medicine, science, ethics, religion, 
law, and engineering. The Commission advises the President on 
bioethical issues arising from advances in biomedicine and related 
areas of science and technology. The Commission seeks to identify and 
promote policies and practices that ensure scientific research, health 
care delivery, and technological innovation are conducted in a socially 
and ethically responsible manner.
    The main agenda item for the Commission's twelfth meeting is to 
continue discussing topics related to the ethical issues associated 
with the development of medical countermeasures for children.
    The draft meeting agenda and other information about the 
Commission, including information about access to the webcast, will be 
available at www.bioethics.gov.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. Respectful debate of opposing views and 
active participation by citizens in public exchange of ideas enhances 
overall public understanding of the issues at hand and conclusions 
reached by the Commission. The Commission is particularly interested in 
receiving comments and questions during the meeting that are responsive 
to specific sessions. Written comments will be accepted at the 
registration desk and comment forms will be provided to members of the 
public in order to write down questions and comments for the Commission 
as they arise. To accommodate as many individuals as possible, the time 
for each question or comment may be limited. If the number of 
individuals wishing to pose a question or make a comment is greater 
than can reasonably be accommodated during the scheduled meeting, the 
Commission may make a random selection.
    Anyone planning to attend the meeting who needs special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at [email protected] in advance of the meeting. 
The Commission will make every effort to accommodate persons who need 
special assistance.

[[Page 76043]]

    Written comments will also be accepted in advance of the meeting 
and are especially welcome. Please address written comments by email to 
[email protected], or by mail to the following address: Public 
Commentary, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Ave. NW., Suite C-100, Washington, DC 20005. Comments 
will be publicly available, including any personally identifiable or 
confidential business information that they contain. Trade secrets 
should not be submitted.

    Dated: December 17, 2012.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2012-31037 Filed 12-21-12; 4:15 pm]
BILLING CODE 4154-06-P